Medium- and longer-term cardiovascular effects of e-cigarettes in adults making a stop-smoking attempt: a randomized controlled trial.

KLONIZAKIS, Markos, GUMBER, Anil, MCINTOSH, Emma and BROSE, Leonie S. (2022). Medium- and longer-term cardiovascular effects of e-cigarettes in adults making a stop-smoking attempt: a randomized controlled trial. BMC Medicine, 20: 276.

[img]
Preview
PDF
Klonizakis-Medium-andLonger-term(VoR).pdf - Published Version
Creative Commons Attribution.

Download (1MB) | Preview
[img]
Preview
PDF
Klonizakis-Medium-andLonger-term(Supp).pdf - Supplemental Material
Creative Commons Attribution.

Download (79kB) | Preview
Official URL: https://bmcmedicine.biomedcentral.com/articles/10....
Open Access URL: https://bmcmedicine.biomedcentral.com/track/pdf/10... (Published version)
Link to published version:: https://doi.org/10.1186/s12916-022-02451-9

Abstract

Background Smoking is a major risk factor for cardiovascular disease and smoking cessation reduces excess risk. E-cigarettes are popular for smoking cessation but there is little evidence on their cardiovascular health effect. Our objective was to compare the medium- and longer-term cardiovascular effects in smokers attempting to quit smoking using e-cigarettes with or without nicotine or prescription nicotine replacement therapy (NRT). Methods This was a single-center, pragmatic three-arm randomized (1:1:1) controlled trial, which recruited adult smokers (≥ 10 cigarettes/day), who were willing to attempt to stop smoking with support (n = 248). Participants were randomized to receive behavioral support with either (a) e-cigarettes with 18 mg/ml nicotine, (b) e-cigarettes without nicotine, and (c) NRT. Flow-mediated dilation (%FMD) and peak cutaneous vascular conductance (CVCmax) responses to acetylcholine (ACh) and sodium nitroprusside (SNP), mean arterial pressure (MAP), and other outcomes were recorded at baseline, 3, and 6 months after stopping smoking. Data were analyzed using generalized estimating equations (GEE). Results At 3- and 6-month follow-up, %FMD showed an improvement over baseline in all three groups (e.g., p < 0.0001 at 6 months). Similarly, ACh, SNP, and MAP improved significantly over baseline in all groups both at 3 and 6 months (e.g., ACh: p = 0.004, at 6 months). Conclusions Smokers attempting to quit experienced positive cardiovascular impact after both a 3- and 6-month period. None of the groups (i.e., nicotine-containing and nicotine-free e-cigarettes or NRT) offered superior cardiovascular benefits to the others.

Item Type: Article
Identification Number: https://doi.org/10.1186/s12916-022-02451-9
Depositing User: Justine Gavin
Date Deposited: 29 Jun 2022 11:35
Last Modified: 12 Oct 2023 10:30
URI: https://shura.shu.ac.uk/id/eprint/30390

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year

View more statistics